Merck & Co. Stock - Analyst consensus and valuation snapshot

Merck & Co. stock remains a core pharma holding as analysts update their models and valuation multiples. A look at current consensus expectations, recent commentary and how the shares are positioned against the broader healthcare sector.

Edited by ad hoc news Analyst & Consensus Desk. Verified prior to publication on 06/18/2026, 11:30 UTC. Details in the imprint.

Merck & Co. (US58933Y1055) remains a key large-cap name in global pharmaceuticals. Analyst services such as Morningstar continue to publish updated fair value estimates and commentary on the company’s earnings power and valuation.

How analysts value Merck today

Data from Morningstar show Merck & Co. trading around the mid-$110s, with an indicated real-time price of roughly $115 per share on the New York Stock Exchange and a published fair value estimate materially above that level.

Morningstar currently cites a fair value estimate near $242 for Merck, implying the stock trades at a discount to its long-term intrinsic value based on the service’s discounted cash flow work.

Consensus earnings and dividend profile

Alongside valuation work, analyst services point to Merck’s role as a dividend payer. Zacks, for example, highlights an annualized dividend of about $3.24 per share, equating to a yield in the mid-single digits at recent prices.

Merck last communicated a quarterly dividend of $0.81 per share in late May 2025, payable to shareholders of record in mid-June 2025, underscoring management’s focus on consistent cash returns.

The product behind the stock

Merck & Co. generates the bulk of its revenue from patented prescription medicines and vaccines, including oncology therapy Keytruda and human papillomavirus vaccine Gardasil, as well as other specialty products in areas such as cardiometabolic disease and infectious diseases.

Where the stock trades today

Merck & Co. shares (US58933Y1055) most recently changed hands on the New York Stock Exchange at approximately $115 per share in US trading, based on the latest real-time quote data available on 06/18/2026, 11:00 UTC.

Key facts on Merck & Co. stock

• Company: Merck & Co., Inc.
• ISIN: US58933Y1055
• WKN: A3EUF3
• Ticker: MRK
• Venue: NYSE
• Price (as of 06/18/2026, 11:00 UTC): 115.00 USD
• Market cap: approximately 290,000,000,000 USD (as of 06/18/2026)
• Sector / Industry: Health Care / Pharmaceuticals
• Index membership: Standard & Poor's 500 index
• Next earnings date: not officially scheduled

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.